메뉴 건너뛰기




Volumn 7, Issue 10, 2012, Pages

Circulating Endothelial Cells and Microparticles as Prognostic Markers in Advanced Non-Small Cell Lung Cancer

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CARBOPLATIN; CISPLATIN; DOCETAXEL; PACLITAXEL; PEMETREXED; PHOSPHATIDYLSERINE; THROMBIN;

EID: 84867514583     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0047365     Document Type: Article
Times cited : (69)

References (37)
  • 1
    • 78049485263 scopus 로고    scopus 로고
    • Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
    • Ferlay J, Shin HR, Bray F, Forman D, Mathers C, et al. (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893-2917.
    • (2010) Int J Cancer , vol.127 , pp. 2893-2917
    • Ferlay, J.1    Shin, H.R.2    Bray, F.3    Forman, D.4    Mathers, C.5
  • 2
    • 0037050352 scopus 로고    scopus 로고
    • Comparison of four chemotherapy regimens for advanced non-small cell lung cancer
    • Schiller JH, Harrington D, Belani CP, Langer C, Sandler A, et al. (2002) Comparison of four chemotherapy regimens for advanced non-small cell lung cancer. N Engl J Med 346: 92-98.
    • (2002) N Engl J Med , vol.346 , pp. 92-98
    • Schiller, J.H.1    Harrington, D.2    Belani, C.P.3    Langer, C.4    Sandler, A.5
  • 3
    • 77950655175 scopus 로고    scopus 로고
    • The emerging role of histology in the choice of first-line treatment of advanced non-small cell lung cancer: implication in the clinical decision-making
    • Rossi A, Maione P, Bareschino MA, Schettino C, Sacco PC, et al. (2010) The emerging role of histology in the choice of first-line treatment of advanced non-small cell lung cancer: implication in the clinical decision-making. Curr Med Chem 17: 1030-1038.
    • (2010) Curr Med Chem , vol.17 , pp. 1030-1038
    • Rossi, A.1    Maione, P.2    Bareschino, M.A.3    Schettino, C.4    Sacco, P.C.5
  • 4
    • 79953793443 scopus 로고    scopus 로고
    • Antiangiogenic agents in combination with chemotherapy in patients with advanced non-small cell lung cancer
    • Ulahannan SV, Brahmer JR, (2011) Antiangiogenic agents in combination with chemotherapy in patients with advanced non-small cell lung cancer. Cancer Invest 29: 325-337.
    • (2011) Cancer Invest , vol.29 , pp. 325-337
    • Ulahannan, S.V.1    Brahmer, J.R.2
  • 6
    • 33646395092 scopus 로고    scopus 로고
    • Circulating endothelial cells, endothelial progenitor cells, and endothelial microparticles in cancer
    • Goon PK, Lip GY, Boos CJ, Stonelake PS, Blann AD, (2006) Circulating endothelial cells, endothelial progenitor cells, and endothelial microparticles in cancer. Neoplasia 8: 79-88.
    • (2006) Neoplasia , vol.8 , pp. 79-88
    • Goon, P.K.1    Lip, G.Y.2    Boos, C.J.3    Stonelake, P.S.4    Blann, A.D.5
  • 7
    • 77952093536 scopus 로고    scopus 로고
    • Circulating endothelial cells as biomarkers in clinical oncology
    • Mancuso P, Bertolini F, (2010) Circulating endothelial cells as biomarkers in clinical oncology. Microvasc Res 79: 224-228.
    • (2010) Microvasc Res , vol.79 , pp. 224-228
    • Mancuso, P.1    Bertolini, F.2
  • 8
    • 0035383784 scopus 로고    scopus 로고
    • Resting and activated endothelial cells are increased in the peripheral blood of cancer patients
    • Mancuso P, Burlini A, Pruneri G, Goldhirsch A, Martinelli G, et al. (2001) Resting and activated endothelial cells are increased in the peripheral blood of cancer patients. Blood 97: 3658-3661.
    • (2001) Blood , vol.97 , pp. 3658-3661
    • Mancuso, P.1    Burlini, A.2    Pruneri, G.3    Goldhirsch, A.4    Martinelli, G.5
  • 9
    • 33846939560 scopus 로고    scopus 로고
    • Endothelial cells in peripheral blood of healthy subjects and patients with metastatic carcinomas
    • Rowand JL, Martin G, Doyle GV, Miller MC, Pierce MS, et al. (2007) Endothelial cells in peripheral blood of healthy subjects and patients with metastatic carcinomas. Cytometry A 71: 105-113.
    • (2007) Cytometry A , vol.71 , pp. 105-113
    • Rowand, J.L.1    Martin, G.2    Doyle, G.V.3    Miller, M.C.4    Pierce, M.S.5
  • 10
    • 0942277099 scopus 로고    scopus 로고
    • Increased levels of viable circulating endothelial cells are an indicator of progressive disease in cancer patients
    • Beerepoot LV, Mehra N, Vermaat JS, Zonnenberg BA, Gebbink MF, et al. (2004) Increased levels of viable circulating endothelial cells are an indicator of progressive disease in cancer patients. Ann Oncol 15: 139-145.
    • (2004) Ann Oncol , vol.15 , pp. 139-145
    • Beerepoot, L.V.1    Mehra, N.2    Vermaat, J.S.3    Zonnenberg, B.A.4    Gebbink, M.F.5
  • 11
    • 73349127099 scopus 로고    scopus 로고
    • Potential of angiogenic growth factors and circulating endothelial cells in breast cancer patients receiving metronomic chemotherapy plus bevacizumab
    • Calleri A, Bono A, Bagnardi V, Quarna J, Mancuso P, et al. (2009) Potential of angiogenic growth factors and circulating endothelial cells in breast cancer patients receiving metronomic chemotherapy plus bevacizumab. Clin Cancer Res 15: 7652-7657.
    • (2009) Clin Cancer Res , vol.15 , pp. 7652-7657
    • Calleri, A.1    Bono, A.2    Bagnardi, V.3    Quarna, J.4    Mancuso, P.5
  • 12
    • 78649484648 scopus 로고    scopus 로고
    • Circulating endothelial cells and endothelial progenitors as predictive markers of clinical response to bevacizumab-based first-line treatment in advanced colorectal cancer patients
    • Ronzoni M, Manzoni M, Mariucci S, Loupakis F, Brugnatelli S, et al. (2010) Circulating endothelial cells and endothelial progenitors as predictive markers of clinical response to bevacizumab-based first-line treatment in advanced colorectal cancer patients. Ann Oncol 21: 2382-2389.
    • (2010) Ann Oncol , vol.21 , pp. 2382-2389
    • Ronzoni, M.1    Manzoni, M.2    Mariucci, S.3    Loupakis, F.4    Brugnatelli, S.5
  • 13
    • 80054691724 scopus 로고    scopus 로고
    • Circulating endothelial cells predict for response to bevacizumab-based chemotherapy in metastatic colorectal cancer
    • Matsusaka S, Suenaga M, Mishima Y, Takagi K, Terui Y, et al. (2011) Circulating endothelial cells predict for response to bevacizumab-based chemotherapy in metastatic colorectal cancer. Chemother Pharmacol 68: 763-768.
    • (2011) Chemother Pharmacol , vol.68 , pp. 763-768
    • Matsusaka, S.1    Suenaga, M.2    Mishima, Y.3    Takagi, K.4    Terui, Y.5
  • 14
    • 65649091778 scopus 로고    scopus 로고
    • Circulating endothelial cells in non-small cell lung cancer patients treated with carboplatin and paclitaxel
    • Kawaishi M, Fujiwara Y, Fukui T, Kato T, Yamada K, et al. (2009) Circulating endothelial cells in non-small cell lung cancer patients treated with carboplatin and paclitaxel. J Thorac Oncol 4: 208-213.
    • (2009) J Thorac Oncol , vol.4 , pp. 208-213
    • Kawaishi, M.1    Fujiwara, Y.2    Fukui, T.3    Kato, T.4    Yamada, K.5
  • 15
    • 3242667696 scopus 로고    scopus 로고
    • Cellular microparticles: a disseminated storage pool of bioactive vascular effectors
    • Morel O, Toti F, Hugel B, Freyssinet JM, (2004) Cellular microparticles: a disseminated storage pool of bioactive vascular effectors. Curr Opin Hematol 11: 156-164.
    • (2004) Curr Opin Hematol , vol.11 , pp. 156-164
    • Morel, O.1    Toti, F.2    Hugel, B.3    Freyssinet, J.M.4
  • 17
    • 68849129712 scopus 로고    scopus 로고
    • Membrane vesicles as conveyors of immune responses
    • Théry C, Ostrowski M, Segura E, (2009) Membrane vesicles as conveyors of immune responses. Nat Rev Immunol 9: 581-593.
    • (2009) Nat Rev Immunol , vol.9 , pp. 581-593
    • Théry, C.1    Ostrowski, M.2    Segura, E.3
  • 18
    • 0031043059 scopus 로고    scopus 로고
    • Pathophysiologic implications of membrane phospholipid asymmetry in blood cells
    • Zwaal RF, Schroit AJ, (1997) Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 89: 1121-1132.
    • (1997) Blood , vol.89 , pp. 1121-1132
    • Zwaal, R.F.1    Schroit, A.J.2
  • 19
    • 49849097799 scopus 로고    scopus 로고
    • Tissue factor-bearing microparticles derived from tumor cells: impact on coagulation activation
    • Davila M, Amirkhosravi A, Coll E, Desai H, Robles L, et al. (2008) Tissue factor-bearing microparticles derived from tumor cells: impact on coagulation activation. J Thromb Haemost 6: 1517-1524.
    • (2008) J Thromb Haemost , vol.6 , pp. 1517-1524
    • Davila, M.1    Amirkhosravi, A.2    Coll, E.3    Desai, H.4    Robles, L.5
  • 20
    • 33846941576 scopus 로고    scopus 로고
    • Tissue factor-positive microparticles: cellular origin and association with coagulation activation in patients with colorectal cancer
    • Hron G, Kollars M, Weber H, Sagaster V, Quehenberger P, et al. (2007) Tissue factor-positive microparticles: cellular origin and association with coagulation activation in patients with colorectal cancer. Thromb Haemost 97: 119-123.
    • (2007) Thromb Haemost , vol.97 , pp. 119-123
    • Hron, G.1    Kollars, M.2    Weber, H.3    Sagaster, V.4    Quehenberger, P.5
  • 21
    • 72549102588 scopus 로고    scopus 로고
    • Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy
    • Zwicker JI, Liebman HA, Neuberg D, Lacroix R, Bauer KA, et al. (2009) Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy. Clin Cancer Res 15: 6830-6840.
    • (2009) Clin Cancer Res , vol.15 , pp. 6830-6840
    • Zwicker, J.I.1    Liebman, H.A.2    Neuberg, D.3    Lacroix, R.4    Bauer, K.A.5
  • 22
    • 8644222225 scopus 로고    scopus 로고
    • Hematopoietic cell-derived microparticle tissue factor contributes to fibrin formation during thrombus propagation
    • Chou J, Mackman N, Merrill-Skoloff G, Pedersen B, Furie BC, et al. (2004) Hematopoietic cell-derived microparticle tissue factor contributes to fibrin formation during thrombus propagation. Blood 104: 3190-3197.
    • (2004) Blood , vol.104 , pp. 3190-3197
    • Chou, J.1    Mackman, N.2    Merrill-Skoloff, G.3    Pedersen, B.4    Furie, B.C.5
  • 23
    • 43749102282 scopus 로고    scopus 로고
    • Microparticle-mediated thrombin generation assay: increased activity in patients with recurrent thrombosis
    • Bidot L, Jy W, Bidot C Jr, Jimenez JJ, Fontana V, et al. (2008) Microparticle-mediated thrombin generation assay: increased activity in patients with recurrent thrombosis. J Thromb Haemost 6: 913-919.
    • (2008) J Thromb Haemost , vol.6 , pp. 913-919
    • Bidot, L.1    Jy, W.2    Bidot Jr., C.3    Jimenez, J.J.4    Fontana, V.5
  • 24
    • 0037220119 scopus 로고    scopus 로고
    • Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: Possible role of a metastasis predictor
    • Kim HK, Song KS, Park YS, Kang YH, Lee YJ, et al. (2003) Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: Possible role of a metastasis predictor. Eur J Cancer 39: 184-191.
    • (2003) Eur J Cancer , vol.39 , pp. 184-191
    • Kim, H.K.1    Song, K.S.2    Park, Y.S.3    Kang, Y.H.4    Lee, Y.J.5
  • 25
    • 54949090343 scopus 로고    scopus 로고
    • Platelet-derived microparticles and coagulation activation in breast cancer patients
    • Toth B, Liebhardt S, Steinig K, Ditsch N, Rank A, et al. (2008) Platelet-derived microparticles and coagulation activation in breast cancer patients. Thromb Haemost 100: 663-669.
    • (2008) Thromb Haemost , vol.100 , pp. 663-669
    • Toth, B.1    Liebhardt, S.2    Steinig, K.3    Ditsch, N.4    Rank, A.5
  • 26
    • 34247606502 scopus 로고    scopus 로고
    • Microparticle-associated tissue factor activity: a link between cancer and thrombosis?
    • Tesselaar ME, Romijn FP, Linden IK, Prins FA, Bertina RM, et al. (2007) Microparticle-associated tissue factor activity: a link between cancer and thrombosis? J Thromb Haemost 5: 520-527.
    • (2007) J Thromb Haemost , vol.5 , pp. 520-527
    • Tesselaar, M.E.1    Romijn, F.P.2    Linden, I.K.3    Prins, F.A.4    Bertina, R.M.5
  • 27
    • 67650531887 scopus 로고    scopus 로고
    • Microvesicles:messengers and mediators of tumor progression
    • Al-Nedawi K, Meehan B, Rak J, (2009) Microvesicles:messengers and mediators of tumor progression. Cell Cycle 8: 2014-2018.
    • (2009) Cell Cycle , vol.8 , pp. 2014-2018
    • Al-Nedawi, K.1    Meehan, B.2    Rak, J.3
  • 28
    • 0034594628 scopus 로고    scopus 로고
    • New guidelines to evaluate the response to treatment in solid tumors (RECIST Guidelines)
    • Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, et al. (2000) New guidelines to evaluate the response to treatment in solid tumors (RECIST Guidelines). J Natl Cancer Inst 92: 205-216.
    • (2000) J Natl Cancer Inst , vol.92 , pp. 205-216
    • Therasse, P.1    Arbuck, S.G.2    Eisenhauer, E.A.3    Wanders, J.4    Kaplan, R.S.5
  • 29
    • 78149252105 scopus 로고    scopus 로고
    • on Behalf Of The ISTH SSC Workshop. Standardization of platelet-derived microparticle enumeration by flow cytometry with calibrated beads: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop
    • Lacroix R, Robert S, Poncelet P, Kasthuri RS, Key NS, et al. (2010) on Behalf Of The ISTH SSC Workshop. Standardization of platelet-derived microparticle enumeration by flow cytometry with calibrated beads: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop. J Thromb Haemost 8: 2571-2574.
    • (2010) J Thromb Haemost , vol.8 , pp. 2571-2574
    • Lacroix, R.1    Robert, S.2    Poncelet, P.3    Kasthuri, R.S.4    Key, N.S.5
  • 30
    • 33645961574 scopus 로고    scopus 로고
    • Isolation and enumeration of circulating endothelial cells by immunomagnetic isolation: proposal
    • Woywodt A, Blann AD, Kirsch T, Erdbruegger U, Banzet N, et al. (2006) Isolation and enumeration of circulating endothelial cells by immunomagnetic isolation: proposal. J Thromb Haemost 4: 671-677.
    • (2006) J Thromb Haemost , vol.4 , pp. 671-677
    • Woywodt, A.1    Blann, A.D.2    Kirsch, T.3    Erdbruegger, U.4    Banzet, N.5
  • 31
    • 79960944057 scopus 로고    scopus 로고
    • Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles
    • György B, Szabó TG, Pásztói M, Pál Z, Misják P, et al. (2011) Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell. Mol. Life Sci 68: 2667-2688.
    • (2011) Cell. Mol. Life Sci , vol.68 , pp. 2667-2688
    • György, B.1    Szabó, T.G.2    Pásztói, M.3    Pál, Z.4    Misják, P.5
  • 32
    • 67651015630 scopus 로고    scopus 로고
    • Platelet microparticles: a potential predictive factor of survival in hormone-refractory prostate cancer patients treated with docetaxel-based chemotherapy
    • Helley D, Banu E, Bouziane A, Banu A, Scotte F, et al. (2009) Platelet microparticles: a potential predictive factor of survival in hormone-refractory prostate cancer patients treated with docetaxel-based chemotherapy. Eur Urol 56: 479-484.
    • (2009) Eur Urol , vol.56 , pp. 479-484
    • Helley, D.1    Banu, E.2    Bouziane, A.3    Banu, A.4    Scotte, F.5
  • 33
    • 78651440657 scopus 로고    scopus 로고
    • High levels of circulating leukocyte microparticles are associated with better outcome in acute respiratory distress syndrome
    • Guervilly C, Lacroix R, Forel JM, Roch A, Camoin-Jau L, et al. (2011) High levels of circulating leukocyte microparticles are associated with better outcome in acute respiratory distress syndrome. Crit Care 15: R31.
    • (2011) Crit Care , vol.15
    • Guervilly, C.1    Lacroix, R.2    Forel, J.M.3    Roch, A.4    Camoin-Jau, L.5
  • 34
    • 77957148097 scopus 로고    scopus 로고
    • Low density lipoprotein receptor mediates anti-VEGF effect of lymphocyte T-derived microparticles in Lewis lung carcinoma cells
    • Yang Ch, Gagnon C, Hou X, Hardy P, (2010) Low density lipoprotein receptor mediates anti-VEGF effect of lymphocyte T-derived microparticles in Lewis lung carcinoma cells. Cancer Biol Ther 10: 448-456.
    • (2010) Cancer Biol Ther , vol.10 , pp. 448-456
    • Yang, C.1    Gagnon, C.2    Hou, X.3    Hardy, P.4
  • 35
    • 78650819812 scopus 로고    scopus 로고
    • Flow cytometric analysis of microparticle phenotype and their role in thrombin generation
    • Macey MG, Enniks N, Bevan S, (2011) Flow cytometric analysis of microparticle phenotype and their role in thrombin generation. Cytometry B Clin Cytom 80: 57-63.
    • (2011) Cytometry B Clin Cytom , vol.80 , pp. 57-63
    • Macey, M.G.1    Enniks, N.2    Bevan, S.3
  • 36
    • 33645551730 scopus 로고    scopus 로고
    • Circulating platelet-derived microparticles in systemic lupus erythematosus. Association with increased thrombin generation and procoagulant state
    • Pereira J, Alfaro G, Goycoolea M, Quiroga T, Ocqueteau M, et al. (2006) Circulating platelet-derived microparticles in systemic lupus erythematosus. Association with increased thrombin generation and procoagulant state. Thromb Haemost 95: 94-99.
    • (2006) Thromb Haemost , vol.95 , pp. 94-99
    • Pereira, J.1    Alfaro, G.2    Goycoolea, M.3    Quiroga, T.4    Ocqueteau, M.5
  • 37
    • 79957517025 scopus 로고    scopus 로고
    • Prediction of venous thromboembolism in patients with cancer by measuring thrombin generation: results from the Vienna Cancer and Thrombosis Study
    • Ay C, Dunkler D, Simanek R, Thaler J, Koder S, et al. (2011) Prediction of venous thromboembolism in patients with cancer by measuring thrombin generation: results from the Vienna Cancer and Thrombosis Study. J Clin Oncol 29: 2099-2103.
    • (2011) J Clin Oncol , vol.29 , pp. 2099-2103
    • Ay, C.1    Dunkler, D.2    Simanek, R.3    Thaler, J.4    Koder, S.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.